US 9,811,638 B2
Means and method for improved glycemic control for diabetic patients
Robert C. Booth, Columbus, OH (US); and Robert E. Fischell, Dayton, MD (US)
Assigned to Aseko, Inc., Greenville, SC (US)
Filed by Aseko, Inc., Greenville, SC (US)
Filed on Oct. 3, 2016, as Appl. No. 15/283,838.
Application 15/283,838 is a continuation of application No. 14/861,427, filed on Sep. 22, 2015, granted, now 9,483,619.
Application 14/861,427 is a continuation of application No. 13/617,776, filed on Sep. 14, 2012, granted, now 9,171,343, issued on Oct. 27, 2015.
Application 13/617,776 is a continuation in part of application No. 13/610,287, filed on Sep. 11, 2012.
Prior Publication US 2017/0024543 A1, Jan. 26, 2017
This patent is subject to a terminal disclaimer.
Int. Cl. G06Q 50/00 (2012.01); G06F 19/00 (2011.01); G06Q 50/22 (2012.01); A61B 5/145 (2006.01); A61M 5/172 (2006.01)
CPC G06F 19/3468 (2013.01) [A61B 5/14532 (2013.01); A61M 5/1723 (2013.01); G06F 19/34 (2013.01); G06F 19/345 (2013.01); G06F 19/3431 (2013.01); G06F 19/3456 (2013.01); G06Q 50/22 (2013.01); A61B 2562/0295 (2013.01)] 22 Claims
OG exemplary drawing
 
1. A method comprising:
receiving, at data processing hardware, an insulin sensitivity factor for a patient and a target blood glucose range defined by upper and lower blood glucose limits for the patient from a medical professional computing device associated with an authorized medical professional;
storing, by the data processing hardware, the insulin sensitivity and the target blood glucose in memory hardware in communication with the data processing hardware;
receiving, at the data processing hardware, a current blood glucose measurement of the patient and a time period of the current blood glucose measurement from a user device controlled by the patient and in communication with the data processing hardware, wherein the user device:
receives the current blood glucose measurement and the time period of the current blood glucose measurement from a blood glucose meter in communication with the user device; and
transmits the current blood glucose measurement of the patient and the time period of the current blood glucose measurement to the data processing hardware;
in response to receiving the current blood glucose measurement from the user device, obtaining, by the data processing hardware, the insulin sensitivity factor for the patient and the target blood glucose range for the patient from the memory hardware;
determining, by the data processing hardware, whether the current blood glucose measurement exceeds a midpoint of the target blood glucose range for the patient; and
when the current blood glucose measurement exceeds the midpoint of the target blood glucose range for the patient:
determining, by the data processing hardware, a correction dose based on a function of the current blood glucose measurement, the mid-point of the target blood glucose range and the insulin sensitivity factor; and
transmitting the correction dose from the data processing hardware to the user device, the correction dose, when received by the user device, causing a user interface executing on the user device to display the correction dose.